Form D · Biotechnology
Zai Lab Ltd
Cambridge, MA · CIK 0001704292
Offering snapshot reported Nov 9, 2026 · SEC filing
- Reported sold
- $250M Offering amount: $250M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 9, 2026 | Initial | $249,933,600 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $7.5M
- Finders' fees
- $0
- Form D file number
- 021-604132
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| LEERINK PARTNERS LLC | 39011 |
Source: Form D, filed Nov 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rafael G. Amado, M.D. | Executive |
| Yajing Chen, Ph.D. | Executive |
| John David Diekman, Ph.D. | Director |
| Samantha (Ying) Du, Ph.D. | Director, Executive |
| F. Ty Edmondson, J.D. | Executive |
| Richard Brian Gaynor, M.D. | Director |
| Nisa Bernice Wing Yu Leung | Director |
| William David Lis | Director |
| Scott William Morrison | Director |
| Leon Oliver Moulder, Jr. | Director |
| Michel Pericles Vounatsos | Director |
| Peter Karl Wirth, J.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
314 Main Street 4 Th Floor, Suite 10
Cambridge, MA, 02142
Cambridge, MA, 02142